BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Holistic medicine
,
Lovastatin
,
rs2476601
,
FABP1
,
Angiogenesis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CA-074
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B.
Caspase-Independent Pathway is Related to Nilotinib Cytotoxicity in Cultured Cardiomyocytes.
A role for the lysosomal protease cathepsin B in zebrafish follicular apoptosis.
Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inh…
NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic i…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Racial/Ethnic in Calcium and Sodium Metabolism
Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or P…
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line P…
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent…
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ